Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
I’m reading it as Apple? Thoughts?
Viable
Treading water? Seriously? I’m looking at a SP up circa 350% over 12 months.
And as concerns news, we all know we get a quarterly update. The last one said:
Accumulated sales orders in Q1 CY2022 totalled 70,200 tonnes, an increase of over 689% compared to the same period last year, and representing:
o 82% of the total 2021 sales orders of 85,000 tonnes
o 47% of the sales target for FY 2022 (150,000 tonnes)
· Experiencing continued increased demand for KP Fértil®
At some point around 30 Jun we all know an update will be due.
Atome MCap now larger than PPC?
And 2Mt forecast for 2023. Plenty of growth to come….
Looks like the Brazilian Real has strengthened by almost 20% vs sterling since the turn of the year. Got to be a good following wind?
I think the RNS is US only.
The figures I quoted were from this link.
https://investor.t-mobile.com/news-and-events/t-mobile-us-press-releases/press-release-details/2022/T-Mobile-Posts-Record-High-Customer-Results-Adding-1.2-Million-Postpaid-Accounts-and-5.5-Million-Postpaid-Customers-in-2021/default.aspx
It seems to imply US numbers - but am happy to admit it could be read differently.
T-Mobile currently has more than 104 million subscribers, of which 84 million are postpaid customers. In 2019, the company had a monthly average revenue per user (ARPU) of 36.86 U.S. dollars and a postpaid churn rate of 0.87 percent in the second quarter of 2021.3 Jan 2022
In Q1 last year we forecast 8kt and achieved 8.8kt. Given the increase in annual forecast from 80kt to 150kt - I would guess our Q1 target is around 15kt mostly in the back half of the quarter. If you apply the statement Brian made that we are running at around 50x forecast for the first 6 weeks of the year - that is simply enormous. Even if we only expected 1kt in the first 6 weeks, that's 50kt (or greater than 50% of last years total sales) in 6 weeks, at the quiet time of year.
I hope his mental maths was good....
Swingy. Where are you accounting for the fixed overheads? I don’t think that is part of the $12 OpEx.
Company guidance has been a 40kt break even figure so (roughly) you need to discount the profit from that tonnage to cover G&A.
On your figures you then get a $2.75m profit - and a valuation that is far in excess of the current MCap as well as an ability to self fund the new projects.
I’m no accountant by the way so happy to be proven wrong!
Have you allowed for the cost savings identified in the 17 Mar 20 RNS. 400k plus further during the year from G&A.
Guessing someone has seen it and it’s good news?
Mention in IC.
https://www.investorschronicle.co.uk/news/2021/11/17/markets-waking-up-to-inflation-threat-and-sending-gold-higher/
LONDON, 08 November 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, notes that its portfolio company Autolus Therapeutics plc (Nasdaq: AUTL) (Autolus), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, has entered into a strategic collaboration and financing agreement with Blackstone (NYSE: BX) under which funds managed by Blackstone Life Sciences ("Blackstone") will provide up to USD250 million in equity and product financing to support Autolus' advancement of its CD19 CAR T cell investigational therapy product candidate, obecabtagene autoleucel (obe-cel), as well as next generation product therapies of obe-cel in B-cell malignancies.
As part of this USD250 million transaction, Blackstone is committing to invest USD150 million in product financing to support obe-cel development and commercialization, with USD50 million payable upon closing of the transaction and the remainder payable based on certain development and regulatory achievements. Blackstone has also agreed to purchase USD100 million of Autolus' American Depositary Shares (ADS) in a private placement, which is subject to customary closing conditions. In connection with the collaboration, Blackstone received the right to nominate a member to Autolus' board of directors.
Arix's existing holding in Autolus is 0.8% and was valued at GBP2.6 million at 30 June 2021.
Money in the bank. No obvious large-scale expenditure pending. Significant (7 figure $ profit). Rapid growth. Long mine life. Low technical risk. And a MCap of circa £6m.
Assuming no nasty, hidden surprises - this should be a matter of time.
Wow!!!! Impressive.
We should get a trading update late this week or early next week. Last year Q3 was nearly 26kt. To meet this years target of 80kt implies sales needs to be around 35kt this quarter. It’s not a precise science but I’d be happy if they remain on track. Obviously it would be even better if they remain ahead of target…..
The following is from CAs final results in 2018. Interesting that they don’t mention how instrumental they were in appointing the chairman they are now trying to remove!
‘In the aftermath of the fundraising, corporate governance shortcomings at the company became apparent. In November 2017, Robert Arnott resigned as chairman with immediate effect, criticising the company’s corporate governance standards. These concerns were publicly shared by the Fund. The company instituted a board committee to address these issues and bring its internal procedures in line with its current size and complexity. As the largest independent shareholder, the Fund engaged intensely with the board over the existing issues and in connection with the recruitment of the new chairman. Steven McTiernan’s appointment as chairman was announced in April. He brings a wealth of experience and having met him before his appointment, we are confident that he will oversee high standards of corporate governance. His M&A experience should help management along the path of asset monetisation. We are pleased that the Fund’s concerns regarding the need to improve corporate governance and standards were not only recognised by the company but are being addressed. We look forward to additional independent directors joining the board.’
Sound familiar?
In order to try and capture the uncertainty range, RPS has considered a low case scenario in which production rates are reduced after an initial period of the field operating normally. This could be due to the complete or partial loss of production from a well for the remainder of the EPS, e.g. due to early water influx from the fracture network and the need to reduce well production rates to control water- production, reductions in well productivity index over time, gradual reduction in ESP performance or some other undefined reduction in production rate. The timing of this event (or combination of events) is uncertain and may be gradual or sudden in nature, depending on the cause. The magnitude of any possible reduction is similarly uncertain.
For the low case, both wells start production at a gross rate of 20,000 bopd (16,000 bopd net @ 80% OE). RPS has arbitrarily selected a sudden 30% reduction in production rates to occur in Year 3 of production based on the discussion above, resulting in net production rates dropping from 16,000 bopd to 11,200 bopd from January 2021 onwards for the remainder of the EPS.
Given the arbitrary nature of the reduction, they were pretty close.
And the CPR low case warned of water breakthrough in the event that the OWC was higher in the structure …..
Published online at COP 6 May. Big spike 7 May. Published in print version yesterday.
And highlighted at the Alpha presentation prior to all of that